Revenue
2022
2023
2024
2025
Syra Health Corp (SYRA)
Price—Loading quote
Net income
2022
2023
2024
2025
Free cash flow
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $7.2M | $8.0M | $5.5M | $5.6M |
| Gross profit | $2.5M | $1.7M | $1.4M | $1.1M |
| Research & development | $67,840 | $585,146 | $240,048 | — |
| Operating expenses | $3.4M | $5.4M | $4.3M | $3.2M |
| Operating income | −$904,324 | −$3.8M | −$2.9M | −$2.1M |
| Net income | −$896,333 | −$3.8M | −$2.9M | −$2.1M |
| Basic EPSper diluted share | -$0.08 | -$0.50 | -$0.60 | -$0.70 |
| Diluted EPSper diluted share | -$0.08 | -$0.50 | -$0.60 | -$0.70 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Sep 12, 2024Form 4 | Prasad PriyaCFO and COO | BuyClass A Common Stock · indirect | 5.3K | $0.38 | $2.0K | 10.3K |
| Feb 8, 2024Form 4 | Prasad PriyaCFO and COO | SellClass A Common Stock · indirect | 500 | $7.50 | $3.8K | 5.0K |
| Dec 21, 2023Form 4 | Prasad PriyaCFO and COO | BuyClass A Common Stock · indirect | 1 | $1.18 | $1.18 | 5.5K |
| Dec 8, 2023Form 4 | Prasad PriyaCFO and COO | BuyClass A Common Stock · indirect | 50 | $1.23 | $61.50 | 5.5K |
| Dec 7, 2023Form 4 | Prasad PriyaCFO and COO | BuyClass A Common Stock · indirect | 10 | $1.22 | $12.20 | 5.4K |